PharmaShots | Incisive News in 3 Shots

Subscribe Now

Clearside Biomedical

Clearside Biomedical Reports P-I/IIa (OASIS) Clinical Trial Results of CLS-AX for the Treatment of Neovascular Age-Related Macular Degeneration

Clearside Biomedical Reports P-I/IIa (OASIS) Clinical Trial Results of CLS-AX for the Treatment of Neovascular Age-Related Macular...

November 10, 2022

Regenxbio Signs an Exclusive Worldwide Option and License Agreement with Clearside Biomedical to Evaluate its Delivery Platform for RGX-314

Regenxbio Signs an Exclusive Worldwide Option and License Agreement with Clearside Biomedical to Evaluate its Delivery Platform fo...

September 4, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us